SciClone Pharmaceuticals Hits New 52-Week High at $7.24 (SCLN)
SciClone Pharmaceuticals (NASDAQ:SCLN) shares reached a new 52-week high during trading on Thursday , AmericanBankingNews.com reports. The company traded as high as $7.24 and last traded at $7.11, with a volume of 503,914 shares. The stock had previously closed at $6.90.
Separately, analysts at Aegis reiterated a “buy” rating on shares of SciClone Pharmaceuticals in a research note on Friday, August 29th.
The stock’s 50-day moving average is $5.63 and its 200-day moving average is $5.04. The company has a market cap of $367.8 million and a price-to-earnings ratio of 16.43.
SciClone Pharmaceuticals (NASDAQ:SCLN) last announced its earnings results on Monday, August 11th. The company reported $0.20 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.10 by $0.10. The company had revenue of $32.50 million for the quarter, compared to the consensus estimate of $33.40 million. During the same quarter last year, the company posted ($0.04) earnings per share. SciClone Pharmaceuticals’s revenue was up 10.9% compared to the same quarter last year. On average, analysts predict that SciClone Pharmaceuticals will post $0.49 earnings per share for the current fiscal year.
SciClone Pharmaceuticals, Inc (NASDAQ:SCLN) is a specialty pharmaceutical company.
Receive News & Ratings for SciClone Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciClone Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.